KLRS
Kalaris Therapeutics Inc
There isn't enough reported data to score KLRS yet.
KLRS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
KLRS's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
KLRS PE Valuation
KLRS has no meaningful PE right now: it lost money over the past year.
KLRS Forward outlook
There aren't enough analyst estimates for KLRS to show an outlook.
KLRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.93 | +$5.52 |
| Q2 2026 | -$2.11 | +$5.62 |
| Q1 2026 | -$2.24 | +$6.03 |
| Q4 2025 | -$4.30 | +$7.43 |
| Q3 2025 | -$7.45 | +$12.56 |
| Q2 2025 | -$7.73 | +$20.33 |
| Q1 2025 | -$8.27 | +$29.68 |
| Q4 2024 | -$11.73 | +$30.36 |
KLRS is still losing money, but far less than before: $1.93 per share over the past year, against $69.46 at its worst in mid-2022.
KLRS Quarterly Revenue
KLRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$11M | +$1.5M |
| Q1 2026 | -$11.6M | -$4.1M |
| Q4 2025 | -$7.1M | -$3.5M |
| Q2 2025 | -$12.5M | -$1.2M |
| Q1 2025 | -$7.4M | +$36.9M |
| Q4 2024 | -$3.6M | +$27.2M |
| Q3 2024 | -$8.4M | +$26M |
| Q2 2024 | -$11.3M | +$15.8M |
KLRS has burned cash in almost every quarter: −$42M over the past year, against −$31M the year before.
KLRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +7.7K shares |
| 1 year | +27% | +5.1M shares |
| 3 years | +479% | +19.7M shares |
| 5 years | +778% | +21.1M shares |
KLRS has 24M diluted shares, up 27% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | — |
| Q4 2019 | — |
KLRS Net Leverage
KLRS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
KLRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.3 | Oversold |
| Stochastic | 11.4 | Oversold |
KLRS's weekly RSI is 29 (oversold) and its Stochastic is 11 (oversold).
KLRS PE vs Healthcare Sector
KLRS has no meaningful PE right now: it lost money over the past year.
KLRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.25 | 26% below |
| 20 week MA | $3.28 | 49% below |
| 50 week MA | $5.62 | 70% below |
| 100 week MA | $5.78 | 71% below |
| 200 week MA | $27.1 | 94% below |
KLRS is in a downtrend: it's below all five of its weekly moving averages, and 94% below its 200-week average.
KLRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $572.7 | $930.6 | +62% |
| 2021 | $930.6 | $315.1 | -66% |
| 2022 | $315.1 | $115.9 | -63% |
| 2023 | $115.9 | $15.6 | -87% |
| 2024 | $15.6 | $10.5 | -33% |
| 2025 | $10.5 | $9.26 | -12% |
| 2026 YTD | $9.26 | $1.66 | -82% |
KLRS has finished five years in a row lower, and it's down 82% so far in 2026.